Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Àkótán ìròyìn
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Tẹ̀lé ìròyìn tuntun láti ọ̀dọ̀ àwọn olùtẹ̀jáde tó ṣeé gbẹ́kẹ̀lé pẹ̀lú àkótán kúkúrú. Ṣí ìjápọ̀ orísun àtilẹ̀wá fún àlàyé.